carboplatin

Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Medical Marketing and Media
Wed, 06/21/23 - 11:51 am
generics
cancer
drug shortages
ADHD
antibiotics
Cisplatin
carboplatin
Final Phase III Data from Study CA031 of ABRAXANE® in Combination with Carboplatin in Patients with Non-Small Cell Lung Cancer Presented at ASCO
Yahoo/BusinessWire
Sun, 06/5/11 - 10:26 am
Abraxane
Celgene
carboplatin
non-small cell lung cancer
Results of Phase 3 ABRAXANE® Combination Trial In First-Line Non-Small Cell Lung Cancer Show 31 Percent Improvement In Response Rate Compared With Taxol Combination
BusinessWire
Sat, 06/5/10 - 12:34 pm
Abraxane
Taxol
carboplatin
companies
non-small cell lung cancer